Surgical Robotics Stocks
Discover investment opportunities in Surgical Robotics Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Surgical Robotics Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Surgical Robotics Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Surgical Robotics Stocks using our Smart AI Filter.
9 stocks found for "Surgical Robotics Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
0.89 | ±29.3% | 17.3 | 0.00% | |||
0.36 | ±21.7% | 15.1 | 3.17% | |||
0.51 | ±20.1% | 29.1 | 0.86% | |||
1.79 | ±77.1% | -6.5 | 0.00% | |||
0.55 | ±61.2% | -3.4 | 0.00% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
1.31 | ±100.0% | -15.8 | 0.00% | |||
0.37 | ±19.7% | 14.7 | 3.18% | |||
0.70 | ±21.9% | 10.9 | 1.04% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How do Intuitive Surgical, Inc. (ISRG) stocks feature in the surgical robotics market?
A: Intuitive Surgical, Inc. is a leader in the surgical robotics market, known for its da Vinci robotic systems. The company has a strong track record of revenue growth, driven by system sales, instrument sales, and services. Investors may find ISRG appealing due to its market dominance and innovation.
Q: What distinguishes Inari Medical (INSP) from other surgical robotics companies?
A: Inari Medical is not directly a surgical robotics company but focuses on medical devices for treating venous diseases. Its inclusion may interest those looking at the broader spectrum of innovative medical technologies.
Q: Are surgical robotics stocks like ISRG and OM suitable for growth-focused investors?
A: Surgical robotics stocks such as ISRG and OM have shown significant growth potential due to technological advancements and increasing adoption in minimally invasive surgeries. These factors could appeal to growth-oriented investors.
Q: How does Vicarious Surgical (VERO) differ from competitors in the surgical robotics industry?
A: Vicarious Surgical is known for its innovative approach combining human-like dexterity robotics with virtual reality applications in surgery. This unique angle could offer competitive advantages in precision and ease of use.
Q: What are the income potential aspects of investing in Asensus Surgical (ASXC)?
A: Asensus Surgical, focusing on performance-guided surgery, may not currently provide high dividend yields, making it less suitable for income-focused investors. Instead, it offers potential capital appreciation through its technological innovations.
Q: Are there sector-specific risks to investing in surgical robotics stocks like GMED and RXST?
A: Surgical robotics stocks face risks from regulatory hurdles, high R&D costs, and the competitive technology-driven environment. Companies like GMED and RXST may also experience fluctuations based on healthcare policies.
The mean of analysts' price targets for Avita Medical (RCEL) points to a 52.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read more